Nutrae Ca-AKG pre-launch product presentation 03
Calcium Alpha-Ketoglutarate · Capsules planned for the UAE private launch

Ca-AKG

Calcium alpha-ketoglutarate presented as a planned single-ingredient capsule with source-linked research context.

250 mg per capsule100 capsulesHalal statuscGMP status
AED 199SALES STARTING SOON

For three bottles, choose one of the four presentation gift boxes.

SALES STARTING SOON
Product facts

One molecule.
99% purity target.

The launch specification remains under final verification. The signed specification, COA, batch records and applicable certificates will be linked only after they are matched to the exact SKU and lot.

Target launch specification

Pending final verification
Active
Calcium alpha-ketoglutarate
Release assay target
99% target
Target amount per capsule
250 mg
Target capsules per bottle
100
Capsule composition
Pending final signed specification
Excipient statement
Pending final signed specification
Filling and stability
Pending verification

View Certificate of Analysis · View Certifications · Batch-record status

Ingredient identity

Ca-AKG is a defined ingredient. Nutrae keeps its planned capsule specification separate from external ingredient research.

Explore the complete record

The exact study form, dose, population, measured results and material boundaries are mapped in Nutrae Science.

Open the evidence record
Human evidence

Source-linked study context.

Selected external studies are summarized with their form and limits. No finding is attributed to the planned Nutrae capsule.

Registered human study · NCT07114536

Ca-AKG study record: results pending.

A randomized, quadruple-masked, placebo-controlled study is evaluating Ca-AKG over 12 weeks, with change in PhenoAge as its primary outcome. No results are posted.

Planned participants
30
Study dose
2 g/day
Duration
12 weeks
Status
Results not yet posted
Open the registered study
Ca-AKG AED 199 NR AED 199 Urolithin A AED 199